Dose Biosystems Inc. Report issue

For profit
Founded: Toronto Ontario Canada (2020)

Organization Overview

First Clinical Trial
2020
NCT04473404
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Dose Biosystems Inc.

Active Ingredients

Drugs in Other Trials (1)

streptococcus salivarius (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 1